Outpatient therapy with piperacillin/tazobactam using elastomeric pumps in patients with Pseudomonas aeruginosa infection
Abstract The aim of this study was to evaluate the efficacy and safety of outpatient antimicrobial therapy with piperacillin-tazobactam in continuous infusion using elastomeric pumps and to evaluate the economic impact compared with conventional hospital treatment in patients with Pseudomonas aerugi...
Guardado en:
Autores principales: | Jose Luis Lamas Ferreiro, Judith Álvarez Otero, Ana Sanjurjo Rivo, Lucía González González, Irene Rodríguez Conde, María Fernández Soneira, Javier Posada García, Javier de la Fuente Aguado |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e67001240094fa9a004bb7c9c0b0b1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SIMULTANEOUS DETERMINATION OF PIPERACILLIN AND TAZOBACTAM IN THE PHARMACEUTICAL FORMULATION TAZONAM® BY DERIVATIVE SPECTROPHOTOMETRY
por: TORAL,M. INÉS, et al.
Publicado: (2012) -
Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients
por: Hasinika K. A. H. Gamage, et al.
Publicado: (2021) -
Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
por: Kohama H, et al.
Publicado: (2017) -
Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla TEM-1B
por: Alasdair T. M. Hubbard, et al.
Publicado: (2020) -
Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in <named-content content-type="genus-species">Escherichia coli</named-content>
por: Lisa M. Schechter, et al.
Publicado: (2018)